Else Nutrition cheers U.S. House legislation

Ms. Hamutal Yitzhak reports ELSE NUTRITION APPLAUDS PIVOTAL U.S. LEGISLATIVE SUPPORT FOR PLANT-BASED, NON-SOY, NON-DAIRY INFANT FORMULA INNOVATION Else Nutrition Holdings Inc. today applauded the U.S. House of Representatives Committee on Appropriations for the full-committee passage of the FY2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill. This landmark legislation includes vital language recognizing the importance of expanding access to alternative infant formulas-specifically plant-based, non-soy and non-dairy formulations -- for a growing number of American families. The accompanying report directs the United States Food and Drug Administration (FDA) to streamline approval pathways for small domestic manufacturers and calls for formal regulatory guidance around non-dairy, non-soy plant-based formulas. These are critical for infants with allergies, intolerances or sensitivities to traditional ingredients -- as well as for families seeking nutritional alternatives aligned with health, lifestyle or ethical values. "This marks a turning point for American families and for Else Nutrition," said Hamutal Yitzhak, chief executive officer and co-founder of Else Nutrition. "For too long, parents have had to choose between limited formula options that may not meet their child's needs. This legislative milestone signals that change is coming -- toward a more inclusive and diversified infant formula landscape. We commend Congress for recognizing this urgent need and taking action that we believe will benefit families for generations to come." Although these types of advanced formulas have gained traction in global markets, regulatory delays have historically constrained innovation in the U.S. market. The recently advanced legislative language is a strong signal to the FDA to establish clear, actionable guidance that can accelerate the availability of safe, effective and scientifically backed alternatives. The report also highlights the Operation Stork Speed initiative, part of the administration's broader effort to fast-track innovation in the infant formula space. By elevating plant-based, non-dairy, non-soy formulations as a key component of this initiative, the legislation reinforces the national commitment to nutritional accessibility and product diversity. While additional legislative steps remain-including passage by the full House -- the inclusion of this language in the committee's final report is a powerful indication of Congressional momentum. Though report language is non-binding, it frequently shapes agency priorities, resource allocation and the pace at which new regulatory frameworks are developed. For Else Nutrition, the implications are clear: the path to broader U.S. market access is becoming more defined. "This is the clearest signal yet that U.S. policymakers are aligned with what we at Else have long championed -- that every child deserves access to safe, effective and nutritionally complete formula options," Ms. Yitzhak added. "We look forward to supporting this important public health mission by working with the FDA and other federal partners to help bring innovative solutions to more families, more quickly." About Else Nutrition Holdings Inc. Else Nutrition Holdings is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support and achieved rapid sales growth. We seek Safe Harbor.